The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.

Insurance and health record data showed about 3% of smokers with peripheral artery disease were prescribed the smoking ...

Age, new comorbidities, inflammation, cognitive reserve, and changes in anxiety levels alter drug effects and recovery.

Derived from early pandemic waves and needing recalibration for new variants, these renal markers and IL 10 could act as ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

France adopts legislation to ease licensing barriers for physicians trained in the UK, whose medical education began before ...

Child death review data show that infant deaths occur in inclined sleepers despite recalls; most incidents happen at home, ...

Nearly 70% of patients with mild-to-moderate Crohn’s disease following a 5-day-per-month fasting-mimicking diet achieve a ...

During follow-up, 12% of those on IL-23 inhibitors and 4.9% of those on bimekizumab developed depression, suicidal ideation, or was on antidepressant or antipsychotic treatment (risk ratio, 2.43; 95% ...

Professor David Kerr examines a massive meta-analysis raising questions about GLP-1 drugs and colorectal cancer risk in ...

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.